Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2003 2
2007 1
2009 1
2010 1
2021 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Potential Therapeutic Role of HDAC Inhibitors in FUS-ALS.
Tejido C, Pakravan D, Bosch LVD. Tejido C, et al. Among authors: bosch lvd. Front Mol Neurosci. 2021 Aug 9;14:686995. doi: 10.3389/fnmol.2021.686995. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34434087 Free PMC article. Review.
FUS Unveiled in Mitochondrial DNA Repair and Targeted Ligase-1 Expression Rescues Repair-Defects in FUS-Linked Neurodegeneration.
Kodavati M, Wang H, Guo W, Mitra J, Hegde PM, Provasek V, Maloji Rao VH, Vedula I, Zhang A, Mitra S, Tomkinson AE, Hamilton DJ, Bosch LVD, Hegde ML. Kodavati M, et al. Among authors: bosch lvd. Res Sq [Preprint]. 2023 Jul 12:rs.3.rs-3152718. doi: 10.21203/rs.3.rs-3152718/v1. Res Sq. 2023. Update in: Nat Commun. 2024 Mar 9;15(1):2156. doi: 10.1038/s41467-024-45978-6 PMID: 37502965 Free PMC article. Updated. Preprint.
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
[Adverse drug reactions. Detection].
Pérez Esquirol E, Bosch LV, de Las Heras-Matellan MJ, Ballarin-Alins E. Pérez Esquirol E, et al. Among authors: bosch lv. Rev Enferm. 2003 Jan;26(1):20-4. Rev Enferm. 2003. PMID: 14509965 Spanish.